• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国关节炎观察研究网络(KORONA):在韩国建立一个前瞻性的多中心类风湿关节炎队列。

Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea.

机构信息

Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea.

出版信息

Semin Arthritis Rheum. 2012 Jun;41(6):745-51. doi: 10.1016/j.semarthrit.2011.09.007. Epub 2011 Dec 9.

DOI:10.1016/j.semarthrit.2011.09.007
PMID:22154221
Abstract

OBJECTIVES

The object of this study was to introduce the KORean Observational study Network for Arthritis (KORONA) registry with an emphasis on the design of the Korean rheumatoid arthritis (RA) national database, as well as to provide an overview of the RA patients who are currently registered in KORONA.

METHODS

The KORONA was established in July 2009 by the Clinical Research Center for Rheumatoid Arthritis (CRCRA) in South Korea. KORONA is based on a prospective protocol and standard, defined data collection instruments. Demographic and clinical features, laboratory and radiologic data, health-related outcomes, treatment side effects, resource utilization, and health behaviors of the RA cohort patients are recorded in a database.

RESULTS

A total of 23 institutions, which are about 38% of the rheumatologic departments at tertiary academic hospitals across South Korea, are part of KORONA. The quality control of data collection and management has been performed through annual monitoring and auditing, staff training, and providing standard operation protocol by the executive committee of CRCRA. As of 31 December 2010, 4721 patients with established RA were included in KORONA, because an annual survey had started to be performed in July 2010.

CONCLUSIONS

KORONA is the first nationwide Korean RA-specific cohort and it will provide valuable "real-world" information for Korean RA patients.

摘要

目的

本研究旨在介绍 KORean 观察性研究网络关节炎(KORONA)登记处,重点介绍韩国类风湿关节炎(RA)国家数据库的设计,并概述目前在 KORONA 登记的 RA 患者。

方法

KORONA 由韩国临床类风湿关节炎研究中心(CRCRA)于 2009 年 7 月成立。KORONA 基于前瞻性方案和标准,定义了数据收集工具。RA 队列患者的人口统计学和临床特征、实验室和放射学数据、健康相关结局、治疗副作用、资源利用和健康行为都记录在数据库中。

结果

共有 23 家机构参与了 KORONA,约占韩国三级学术医院风湿病科的 38%。CRCRA 执行委员会通过年度监测和审计、员工培训以及提供标准操作方案,对数据收集和管理的质量控制进行了管理。截至 2010 年 12 月 31 日,已有 4721 例确诊的 RA 患者纳入 KORONA,因为自 2010 年 7 月开始进行年度调查。

结论

KORONA 是第一个全国性的韩国 RA 特定队列,它将为韩国 RA 患者提供有价值的“真实世界”信息。

相似文献

1
Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea.韩国关节炎观察研究网络(KORONA):在韩国建立一个前瞻性的多中心类风湿关节炎队列。
Semin Arthritis Rheum. 2012 Jun;41(6):745-51. doi: 10.1016/j.semarthrit.2011.09.007. Epub 2011 Dec 9.
2
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.类风湿关节炎中改善病情抗风湿药(DMARDs)和生物制剂的真实世界使用情况:RADIUS(类风湿关节炎改善病情抗风湿药干预与使用研究)研究
Curr Med Res Opin. 2006 Jan;22(1):169-83. doi: 10.1185/030079906X80341.
3
The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis.韩国类风湿关节炎患者骨质疏松症的发生率及危险因素
BMC Musculoskelet Disord. 2016 Feb 24;17:98. doi: 10.1186/s12891-016-0952-8.
4
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.特定生物制剂和改善病情抗风湿药单药治疗及联合治疗在类风湿关节炎治疗中的真实世界疗效:来自RADIUS观察性注册研究的结果
Curr Med Res Opin. 2006 Jan;22(1):185-98. doi: 10.1185/030079905X65510.
5
Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.比较类风湿关节炎数据库中的抗 TNF 治疗起始情况表明,抗 TNF 治疗起始时患者参数在各国之间存在很大差异。
Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004. Epub 2010 Dec 17.
6
Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.韩国类风湿关节炎(RA)患者的结核病发病率:RA本身及肿瘤坏死因子阻滞剂的影响
J Rheumatol. 2007 Apr;34(4):706-11. Epub 2007 Feb 15.
7
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.与新诊断类风湿关节炎开始使用疾病修正抗风湿药物相关的因素:一项回顾性理赔数据库研究。
Clin Ther. 2012 Feb;34(2):457-67. doi: 10.1016/j.clinthera.2011.12.016. Epub 2012 Jan 28.
8
Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.美国一项观察性队列研究中类风湿关节炎患者肿瘤坏死因子抑制剂的使用趋势
J Rheumatol. 2009 Aug;36(8):1611-7. doi: 10.3899/jrheum.080889. Epub 2009 Apr 15.
9
Factors Associated with the Use of Complementary and Alternative Medicine for Korean Patients with Rheumatoid Arthritis.韩国类风湿性关节炎患者使用补充和替代医学的相关因素。
J Rheumatol. 2015 Nov;42(11):2075-81. doi: 10.3899/jrheum.141447. Epub 2015 Sep 1.
10
Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.抗肿瘤坏死因子治疗:以色列北部单一中心的6年经验及卫生政策对结果的可能影响。
Isr Med Assoc J. 2008 Apr;10(4):277-81.

引用本文的文献

1
High-Titer Rheumatoid Factor is Associated with Worse Clinical Outcomes and Higher Needs for Advanced Therapies in Rheumatoid Arthritis Under Real-Life Conditions.在现实生活条件下,高滴度类风湿因子与类风湿关节炎更差的临床结局及对先进治疗的更高需求相关。
Rheumatol Ther. 2025 Feb;12(1):123-136. doi: 10.1007/s40744-024-00730-w. Epub 2024 Dec 19.
2
Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency.社会经济地位对类风湿关节炎生物制剂使用的影响:揭示不平等和医疗保健效率。
Korean J Intern Med. 2024 Jul;39(4):668-679. doi: 10.3904/kjim.2023.276. Epub 2024 Feb 29.
3
Prediction of osteoporosis in patients with rheumatoid arthritis using machine learning.
利用机器学习预测类风湿关节炎患者的骨质疏松症。
Sci Rep. 2023 Dec 9;13(1):21800. doi: 10.1038/s41598-023-48842-7.
4
Epidemiology of Rheumatoid Arthritis in Korea.韩国类风湿关节炎的流行病学
J Rheum Dis. 2021 Apr 1;28(2):60-67. doi: 10.4078/jrd.2021.28.2.60.
5
Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis.绝经年龄对绝经后类风湿关节炎女性疾病结局的影响:一项韩国类风湿关节炎患者的大型观察性队列研究。
RMD Open. 2023 Feb;9(1). doi: 10.1136/rmdopen-2022-002722.
6
Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance.埃及风湿病学院(ECR)的类风湿关节炎研究:全国性介绍和世界性立场。
Rheumatol Int. 2023 Apr;43(4):667-676. doi: 10.1007/s00296-022-05258-2. Epub 2023 Jan 8.
7
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis.基线骨侵蚀和时间平均 DAS28 预测类风湿关节炎中 TNF 抑制剂的停药。
Sci Rep. 2022 Nov 19;12(1):19951. doi: 10.1038/s41598-022-24027-6.
8
Incidence and prevalence of seropositive rheumatoid arthritis among Korean women of childbearing age: a nationwide population-based study.韩国育龄女性血清阳性类风湿关节炎的发病率和患病率:一项全国性基于人群的研究。
Korean J Intern Med. 2023 Jan;38(1):125-133. doi: 10.3904/kjim.2021.339. Epub 2022 May 19.
9
TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.TNF 抑制剂会增加分枝杆菌结核流行地区血清阳性类风湿关节炎患者发生非结核分枝杆菌的风险。
Sci Rep. 2022 Mar 7;12(1):4003. doi: 10.1038/s41598-022-07968-w.
10
Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea.类风湿关节炎患者恶性肿瘤的患病率、发病率和危险因素:来自韩国的全国性队列研究。
Korean J Intern Med. 2023 Jan;38(1):113-124. doi: 10.3904/kjim.2021.146. Epub 2021 Aug 20.